Cardlytics (CDLX)

Nasdaq Market Closed

Cardlytics, Inc. is a commerce media and marketing technology company that connects advertisers with consumers through financial institutions’ digital banking channels. Its core Cardlytics platform places targeted offers and rewards inside online and mobile banking experiences operated by partner banks and financial services providers. This position gives the company access to purchase signals from bank transaction data, which marketers can use to reach consumers based on actual spending behavior rather than inferred interest alone.

The company’s model is built around measurable performance marketing. Brands use Cardlytics to promote products, drive store or online sales, and reward customers with cash-back or similar incentives after qualifying purchases. Because the offers are linked to payment activity, the platform can help advertisers evaluate whether campaigns translate into real transactions. Cardlytics operates this business in the United States and the United Kingdom, with the U.S. Cardlytics platform representing the largest contributor to revenue.

Cardlytics also owns Bridg, an identity resolution and customer data platform focused on point-of-sale data. Bridg helps marketers, including retailers and restaurants, connect purchase-level information with customer profiles for analytics, loyalty marketing, and campaign measurement. Together, the Cardlytics and Bridg platforms place the company in the broader commerce media market, where retailers, banks, and data-driven media networks compete to turn transaction data into advertising value. Cardlytics’ distinctive feature is its integration with financial media channels, giving advertisers a way to engage consumers in trusted banking environments while tying promotions to verified spending outcomes.

0.60 USD
0.61 USD
−0.01 (-1.92%)
After-hours

Last updated

Market Cap
35.43M
P/E
P/FCF
3.56
P/S
0.17
Enterprise Value
203.96M
Sector
Industry
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA, 30308
GlobeNewswire Inc.

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

15 Mar 2025, 12:35 PM
GlobeNewswire Inc.

CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

21 Feb 2025, 22:00 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman

14 Feb 2025, 19:05 PM
GlobeNewswire Inc.

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Cardlytics, Inc. (NASDAQ: CDLX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

13 Feb 2025, 23:55 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman

13 Feb 2025, 01:05 AM
GlobeNewswire Inc.

Cardlytics, Inc. Shareholders with Large Losses Should Contact Robbins LLP for Information About the CDLX Class Action Lawsuit

12 Feb 2025, 01:04 AM
GlobeNewswire Inc.

Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact The Gross Law Firm

06 Feb 2025, 19:46 PM
GlobeNewswire Inc.

CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

04 Feb 2025, 22:00 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman

29 Jan 2025, 03:32 AM
GlobeNewswire Inc.

CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

28 Jan 2025, 22:00 PM
GlobeNewswire Inc.

Cardlytics, Inc. Announcement: If You Have Suffered Losses in Cardlytics, Inc. (NASDAQ: CDLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

25 Jan 2025, 01:00 AM
GlobeNewswire Inc.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLX

20 Jan 2025, 16:42 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

16 Sept 2024, 22:52 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

19 Aug 2024, 21:58 PM
GlobeNewswire Inc.

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

13 Aug 2024, 23:34 PM
GlobeNewswire Inc.

Liane Hornsey Appointed to Cardlytics Board of Directors

09 Apr 2024, 21:02 PM
GlobeNewswire Inc.

Cardlytics Prices $150.0 Million Convertible Senior Notes Offering

27 Mar 2024, 02:15 AM
GlobeNewswire Inc.

Cardlytics Announces Proposed Convertible Senior Notes Offering

26 Mar 2024, 12:13 PM
GlobeNewswire Inc.

Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results

14 Mar 2024, 21:03 PM
GlobeNewswire Inc.

Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 Mar 2024, 22:05 PM
Market Cap
35.43M
Enterprise Value
203.96M
P/E
P/B
-8.85
P/S
0.17
EV / EBITDA
-15.28
EV / Sales
0.99
EPS
-1.63
Dividend Yield
0%
P/FCF
3.56
P/CF
3.42
Free Cash Flow
9.97M
ROE
2,365.38%
ROA
-35.88%
Debt / Equity
-51.01
Current Ratio
2.17
Quick Ratio
2.17
Cash
0.6
Avg Volume
793K
Fundamentals Snapshot Price
0.61

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 34.32M 56.1M 52.03M 63.25M 56.44M
Gross profit 31.74M 128.84M 24.3M 63.25M 50.65M
Operating income -8.27M -6.1M -68.53M -12.59M -16.47M
EBITDA -3.86M 671K -3.22M -6.95M -10.17M
Net income -4.48M -8.25M -72.67M -9.28M -13.28M
Basic EPS -0.08 -0.14 -1.36 -0.18 -0.26
Diluted EPS -0.08 -0.14 -1.36 -0.18 -0.26

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 263.91M 285.64M 292.81M 361.13M 369.07M
Total liabilities 267.91M 292.15M 297.51M 302.43M 304.98M
Total equity -4M -6.51M -4.7M 58.71M 64.09M
Cash & equivalents 35.67M 48.72M 43.96M 46.75M 52.05M
Current assets 128.52M 137.28M 140.71M 150.4M 156.83M
Current liabilities 59.35M 76.82M 123.7M 129.15M 131.85M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -5.64M 13.01M 1.76M 1.23M -6.71M
Investing cash flow -2.3M -2.28M -4.46M -4.66M -3.9M
Financing cash flow -5.02M -6.02M -12K -2.06M -3.03M
Change in cash -13.05M 4.76M -2.78M -5.3M -13.55M
Kind Filing Date Link
edgar index 8-K — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 8-K — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Klinck John L. Jr. View Filing
form 4 Form 4 — Klinck John L. Jr. View Filing
form 4 Form 4 — Klinck John L. Jr. View Filing
form 4 Form 4 — Hornsey Liane View Filing
form 4 Form 4 — Hornsey Liane View Filing
form 4 Form 4 — Hornsey Liane View Filing
form 4 Form 4 — Fernandez Andre J View Filing
form 4 Form 4 — Fernandez Andre J View Filing
form 4 Form 4 — Fernandez Andre J View Filing
form 4 Form 4 — Hill Scott A View Filing
form 4 Form 4 — Hill Scott A View Filing
form 4 Form 4 — Hill Scott A View Filing
form 4 Form 4 — Francis Jonathan Edward View Filing
form 4 Form 4 — Francis Jonathan Edward View Filing
form 4 Form 4 — Francis Jonathan Edward View Filing
form 4 Form 4 — Gupta Srishti A. View Filing
form 4 Form 4 — Gupta Srishti A. View Filing
form 4 Form 4 — Gupta Srishti A. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
form 4 Form 4 — Evans David Thomas View Filing
form 4 Form 4 — Evans David Thomas View Filing
edgar index 8-K — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Cardlytics, Inc. View Filing
edgar index 10-Q — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index DEF 14A — Cardlytics, Inc. View Filing
edgar index DEFA14A — Cardlytics, Inc. View Filing
edgar index ARS — Cardlytics, Inc. View Filing
edgar index 144 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 144 — Cardlytics, Inc. View Filing
form 4 Form 4 — Gupta Amit View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 4 — Cardlytics, Inc. View Filing
edgar index 144 — Cardlytics, Inc. View Filing
form 4 Form 4 — Gupta Amit View Filing
edgar index 144 — Cardlytics, Inc. View Filing
edgar index 144 — Cardlytics, Inc. View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Lynton Nicholas Hollmeyer View Filing
form 4 Form 4 — Gupta Amit View Filing
form 4 Form 4 — Gupta Amit View Filing
form 4 Form 4 — Gupta Amit View Filing
form 4 Form 4 — Gupta Amit View Filing
form 4 Form 4 — Gupta Amit View Filing
edgar index PRE 14A — Cardlytics, Inc. View Filing
edgar index 144 — Cardlytics, Inc. View Filing
edgar index 8-K — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index S-8 — Cardlytics, Inc. View Filing
edgar index 8-K — Cardlytics, Inc. View Filing
edgar index 10-K — Cardlytics, Inc. View Filing
eight k text 8-K — 8-K View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing